Buffington Mohr McNeal Grows Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Buffington Mohr McNeal boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 507 shares of the medical equipment provider’s stock after purchasing an additional 31 shares during the period. Buffington Mohr McNeal’s holdings in Intuitive Surgical were worth $265,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of ISRG. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 42,265 shares of company stock valued at $21,964,281. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.8 %

ISRG opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock’s 50 day moving average price is $547.16 and its two-hundred day moving average price is $505.21.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Wells Fargo & Company raised their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday. Robert W. Baird lifted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.